and in adults with type 2 diabetes mellitus. See Safety Info. which may affect their blood glucose. Click here for Full Prescribing Information for Lantus. starting dose for your patients with type 2 diabetes. See Safety Info. are rounded down to the nearest whole unit. (From Lantus® Prescribing Information.) . See Safety Info. or innovator, product; Currently, there are no FDA- approved AB/AP-rated follow-on biologic insulins1 More info on follow-on biologics +.
|Published (Last):||27 June 2009|
|PDF File Size:||7.45 Mb|
|ePub File Size:||10.5 Mb|
|Price:||Free* [*Free Regsitration Required]|
The patient’s ability to concentrate and react may be impaired as a result of hypoglycemia.
LANTUS® (insulin glargine injection) solution for subcutaneous injection Prescribing Information
Lantus is a clear insulin. Your healthcare provider will tell you if your insulin dose presrcibing to lantus prescribing information changed. Patients should be advised not to share disposable or reusable insulin devices or needles with other patients, because doing so carries a risk for transmission of blood-borne pathogens.
Usually, it means there is not enough insulin to break down the food you eat into energy your body can use. You should always make sure that:. Lantus prescribing information must prescribkng at the tip of the needle. Hyperglycemia can be caused by a fever, an infection, stress, eating more than you should, taking less insulin than prescribed, or it can mean your diabetes is getting worse.
Insulin glargine was not mutagenic in tests for detection of gene mutations in bacteria and mammalian cells Ames- and HGPRT-test and in lantus prescribing information for detection of chromosomal aberrations cytogenetics in vitro in V79 cells and in vivo in Chinese hamsters. Has not been studied in children with type 2 diabetes.
The Cartridge System and Pen Body do not click back together properly: The mean HbA1c SD at the end of the trial prscribing 6.
Other factors which may increase the risk of hypoglycemia include changes in meal pattern e. Severe, life-threatening, generalized allergy, including anaphylaxis, generalized skin reactions, angioedema, bronchospasm, hypotension, and shock may occur with any insulin, including LANTUS prescrbiing may be life threatening. The 10 mL vial presentation contains the following inactive ingredients per mL: In elderly patients with diabetes, the initial dosing, dose increments, and maintenance dosage should be conservative invormation avoid lantus prescribing information reactions.
Blood glucose monitoring is essential in all lantus prescribing information receiving insulin therapy. The recommended lantus prescribing information dose of LANTUS in patients with type 2 diabetes who are not currently treated with insulin is 10 units or 0.
Study G 5 years Regular insulin. Ask your healthcare provider what your blood sugar should be and when you should check your blood sugar levels.
Patients and caregivers must be educated to recognize and manage hypoglycemia. If you are using a new vial, remove the protective cap. Sharing poses a prescrkbing of transmission of blood borne pathogens. If you use a lantus prescribing information other than a U insulin lantus prescribing information, you may get the wrong dose of insulin. If you continue to dial after reaching 80 units, insulin will drip from the needle and the display will continue to show “80”.
Preecribing and Administration 2.
For patients that use two different lantus prescribing information of insulin, Lantus or Lantux, it is recommended to use a different color pen for each insulin. Medication errors have been reported in which other insulins, particularly short-acting insulins, have been accidentally administered instead of LANTUS [See Patient Counseling Information 17 ].
Do not allow it to freeze.
Disposable needle should be used only once. Instruct patients on handling lantus prescribing information special situations such as intercurrent conditions illness, stress, or emotional disturbancesan inadequate or skipped insulin dose, inadvertent administration of an increased insulin dose, inadequate food intake, and skipped meals.
Pentamidine may cause hypoglycemia, which may sometimes be followed by hyperglycemia. In Study B, the average lantus prescribing information was The presence of such insulin antibodies may increase or decrease the efficacy of insulin and may lantus prescribing information adjustment of the insulin dose. In mice and rats, standard two-year carcinogenicity studies with insulin lantu were performed at doses up to 0.